Literature DB >> 27668091

Cancer nanomedicine: Is targeting our target?

Twan Lammers1, Fabian Kiessling2, Marianne Ashford3, Wim Hennink4, Daan Crommelin4, Gert Storm5.   

Abstract

Nanomedicine may have a delivery problem. Rigorous, realistic and holistic rethinking is needed to improve nanomedicine performance and increase patient benefit.

Entities:  

Year:  2016        PMID： 27668091      PMCID： PMC5034892          DOI： 10.1038/natrevmats.2016.69

Source DB:  PubMed          Journal:  Nat Rev Mater        ISSN： 2058-8437            Impact factor:   66.308


  4 in total

1.  Nanomedicine gets personal.

Authors:  Gregory T Tietjen; W Mark Saltzman
Journal:  Sci Transl Med       Date:  2015-11-18       Impact factor: 17.956

Review 2.  Personalized nanomedicine.

Authors:  Twan Lammers; Larissa Y Rizzo; Gert Storm; Fabian Kiessling
Journal:  Clin Cancer Res       Date:  2012-07-24       Impact factor: 12.531

Review 3.  Cancer nanomedicines: so many papers and so few drugs!

Authors:  Vincent J Venditto; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2012-10-01       Impact factor: 15.470

4.  Does Nanomedicine Have a Delivery Problem?

Authors:  Michael Torrice
Journal:  ACS Cent Sci       Date:  2016-07-15       Impact factor: 14.553
  4 in total
  46 in total

1.  Imaging-guided revival of nanomedicine?

Authors:  Max L Senders; Zahi A Fayad; Thomas Reiner; Willem Jm Mulder; Carlos Pérez-Medina
Journal:  Nanomedicine (Lond)       Date:  2016-11-23       Impact factor: 5.307

2.  Lessons from immuno-oncology: a new era for cancer nanomedicine?

Authors:  Wen Jiang; Hengfeng Yuan; Charles K Chan; Christina A von Roemeling; Zuoqin Yan; Irving L Weissman; Betty Y S Kim
Journal:  Nat Rev Drug Discov       Date:  2017-03-17       Impact factor: 84.694

Review 3.  Tumor targeting via EPR: Strategies to enhance patient responses.

Authors:  Susanne K Golombek; Jan-Niklas May; Benjamin Theek; Lia Appold; Natascha Drude; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2018-07-19       Impact factor: 15.470

Review 4.  Minimum information reporting in bio-nano experimental literature.

Authors:  Matthew Faria; Mattias Björnmalm; Kristofer J Thurecht; Stephen J Kent; Robert G Parton; Maria Kavallaris; Angus P R Johnston; J Justin Gooding; Simon R Corrie; Ben J Boyd; Pall Thordarson; Andrew K Whittaker; Molly M Stevens; Clive A Prestidge; Christopher J H Porter; Wolfgang J Parak; Thomas P Davis; Edmund J Crampin; Frank Caruso
Journal:  Nat Nanotechnol       Date:  2018-09-06       Impact factor: 39.213

Review 5.  Applying nanomedicine in maladaptive inflammation and angiogenesis.

Authors:  Amr Alaarg; Carlos Pérez-Medina; Josbert M Metselaar; Matthias Nahrendorf; Zahi A Fayad; Gert Storm; Willem J M Mulder
Journal:  Adv Drug Deliv Rev       Date:  2017-05-12       Impact factor: 15.470

6.  Combining Nanomedicine and Immunotherapy.

Authors:  Yang Shi; Twan Lammers
Journal:  Acc Chem Res       Date:  2019-05-23       Impact factor: 22.384

7.  Poly(cyclodextrin)-Polydrug Nanocomplexes as Synthetic Oncolytic Virus for Locoregional Melanoma Chemoimmunotherapy.

Authors:  Jihoon Kim; Lauren F Sestito; Sooseok Im; Won Jong Kim; Susan N Thomas
Journal:  Adv Funct Mater       Date:  2020-02-24       Impact factor: 18.808

Review 8.  Nanomaterial-Enabled Cancer Therapy.

Authors:  Sabina Quader; Kazunori Kataoka
Journal:  Mol Ther       Date:  2017-05-19       Impact factor: 11.454

9.  Polyester Nanoparticle Encapsulation Mitigates Paclitaxel-Induced Peripheral Neuropathy.

Authors:  R Ganugula; M Deng; M Arora; H-L Pan; M N V Ravi Kumar
Journal:  ACS Chem Neurosci       Date:  2019-01-17       Impact factor: 4.418

Review 10.  Molecular imaging with nanoparticles: the dwarf actors revisited 10 years later.

Authors:  Gudrun C Thurner; Paul Debbage
Journal:  Histochem Cell Biol       Date:  2018-11-16       Impact factor: 4.304
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.